<img alt="" height="1" width="1" />
FDA staff say Merck's Vytorin helps kidney patients
Reuters
(Reuters) - Drugs reviewers said Merck's cholesterol-lowering drug Vytorin was effective in reducing the rate of heart attacks or other cardiovascular problems in patients with kidney disease. Reviewers from the US Food and Drug Administration also ...
FDA Gives Favorable Review to SHARP Ahead of Vytorin Advisory PanelForbes
all 11 news articles »
More...